Clinical trials: sponsored by ANRS, Emerging Infectious Diseases
HIV Infections, Tuberculosis
Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in Vietnam
The overall aim of the project is to evaluate rifabutin (RBT) as a replacement for rifampicin (RMP), for the combined treatment of tuberculosis and HIV infection.
- Trial name
- NCT00651066
- Testing
- rifabutin in combination with lopinavir boosted by ritonavir - dosing schedule 1, rifabutin in combination with lopinavir boosted by ritonavir - dosing schedule 2
- Where
- Vietnam
- Volunteers
- 47 people
- Sponsor
- French National Agency for Research on AIDS and Viral Hepatitis
HIV Infections
Evaluation of the Extension at Community Level of Safe Male Circumcision (ANRS 12126 ORANGE FARM 2)
This study is aimed at demonstrating whether or not Male Circumcision can be used as an effective public health prevention tool that will have an impact on HIV prevalence in the South African population.
- Trial name
- ORANGE FARM 2 (NCT00623051)
- Testing
- Male Circumcision
- Where
- South Africa
- Volunteers
- 27,000 people, healthy volunteers welcome
- Sponsor
- French National Agency for Research on AIDS and Viral Hepatitis
Chronic Hepatitis B, AgHbs Negativation
A Randomized Study to Assess the Loss of HbsAg After a 48-week Treatment Period With Pegylated Interferon Alpha 2a in Patients With Chronic Hepatitis B
The purpose of this study is to assess the loss of HbsAg after a 48-week pegylated interferon alpha 2a in patients with chronic hepatitis B (HBeAg negativation)
- Trial name
- PEGAN (NCT01172392)
- Testing
- Pegylated interferon-alpha-2a, Nucleotidic or Nucleosidic Treatment
- Where
- France
- Volunteers
- 185 people
- Sponsor
- ANRS, Emerging Infectious Diseases
HIV Infections
Study of Human Papillomavirus Related Genital Pathology Among HIV Positive Women
This study is a Multicentre cohort study with inclusion throughout the full duration of the study. The primary objective is the study of human papillomavirus related genital pathology in HIV positive women.
- Trial name
- ANRS CO17 (NCT01311752)
- Testing
- surgical management of high grade lesions
- Volunteers
- 676 people
- Sponsor
- French National Agency for Research on AIDS and Viral Hepatitis
HIV Infection
Patients Infected With HIV Since More Than 10 Years With a Plasma Viral RNA <400 Copies / mL in the Absence of Any Treatment: Study Mechanisms Involved in Controlling the Infection
The investigators have previously described a limited group of HIV-1-infected patients, we called HIV controllers (HIC), who have been infected for more than 10 years, in whom viral replication is spontaneously controlled without…
- Trial name
- ANRS CO18 (NCT01065207)
- Testing
- blood test at day one
- Where
- France
- Volunteers
- 250 people
- Sponsor
- French National Agency for Research on AIDS and Viral Hepatitis
HIV Infection, Aging Accelerated
Accelerated Aging, HIV Infection, Antiretroviral Therapies
The main goal is to confirm, among HIV1-infected patients, data from in vitro studies showing that antiretroviral therapies induce an accelerated aging through the same mechanisms than genetic laminopathies or than "physiological…
- Conditions
- HIV Infection, Aging Accelerated, Antiretroviral Therapies
- Trial name
- EP 45 (NCT01038999)
- Testing
- Peripheral blood biological tests
- Where
- France
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- French National Agency for Research on AIDS and Viral Hepatitis
HIV
A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir
In the well recognized context of HIV infection chronicity, it is now crucial to identify and evaluate effective, well tolerated and affordable second line regimen in resources limited countries where patients often change…
- Trial name
- ALISA (NCT01255371)
- Testing
- Lopinavir, Atazanavir
- Where
- 2 sites in South Africa, Tanzania
- Sponsor
- ANRS, Emerging Infectious Diseases
Hepatitis C, Substance Dependence
Initialization of Methadone in Primary Care, Randomized Intervention Research for Preventing HCV Transmission Practices
The rapid scale up of opioid substitution treatment (OST) for drug users mainly achieved through the possibility of prescribing buprenorphine in primary care has been successful in reducing HIV prevalence among drug users but…
- Conditions
- Hepatitis C, Substance Dependence, Methadone
- Trial name
- Methaville (NCT00657397)
- Testing
- Methadone
- Where
- France
- Volunteers
- 197 people
- Sponsor
- French National Agency for Research on AIDS and Viral Hepatitis
Liver Transplantation, Hepatitis C
Treatment of Recurrent Hepatitis C After Liver Transplantation
In France, 50% of the hepatitis C virus carriers develop chronic clinical hepatitis, which may lead to cirrhosis and liver transplantation. Transplant infection by hepatitis C virus is constant after transplantation.
- Trial name
- TRANSPEG (NCT00151580)
- Testing
- Ribavirin
- Where
- 16 sites in France
- Volunteers
- 200 people
- Sponsor
- Rennes University Hospital
HIV Infections
Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA)
The goal of this trial is to demonstrate that new treatments are as effective as a reference triple-agent regimen in driving plasma viral load below the detection limit early during treatment (16 weeks).
- Trial name
- DAYANA (NCT00573001)
- Testing
- Tenofovir/Emtricitabine (Truvada) and Nevirapine, Tenofovir/Emtricitabine/Efavirenz (Atripla), Tenofovir (Viread) and Lopinavir/Ritonavir (Aluvia)
- Where
- 2 sites in Cameroon, Senegal
- Volunteers
- 120 people
- Sponsor
- French National Agency for Research on AIDS and Viral Hepatitis
HIV Infection, Tuberculosis
Early vs Late Introduction of Antiretroviral Therapy in HIV-infected Patients With Tuberculosis (ANRS 1295 CAMELIA)
In Cambodia the prevalence of both tuberculosis (TB) and Human Immunodeficiency Virus (HIV) infection is high. Data suggest that aggressive management of HIV infection, which includes Anti-Retroviral Therapy (HAART) during…
- Trial name
- NCT00226434
- Testing
- Early antiretroviral treatment, Late antiretroviral treatment
- Where
- 5 sites in Cambodia
- Volunteers
- 661 people
- Sponsor
- French National Agency for Research on AIDS and Viral Hepatitis
Obesity
Protein Nutrition During Weight Loss
The purpose of this study is to minimize the loss of lean body mass that occurs during a weight-loss program in obese people by changing the nature of ingested protein and the pattern of protein feeding
- Trial name
- SURPROL-CF-H (NCT00690781)
- Testing
- Pulse casein feeding during energy restriction, Spread casein feeding during energy restriction, Pulse milk soluble protein feeding during energy restriction
- Where
- France
- Volunteers
- 48 people
- Sponsor
- Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
HIV Infections
Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx
This study will examine whether interleukin-2 (IL-2) given before the interruption of antiretroviral (ARV) treatment could significantly extend the period of time that a patient is temporarily not taking ARV treatment and also…
- Trial name
- ILIADE (NCT00071890)
- Testing
- Interleukin 2, HAART, Treatment interruption
- Where
- 2 sites in United States, France
- Volunteers
- 148 people
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections, Pregnancy
Nevirapine Plus Zidovudine to Prevent Perinatal HIV in Thailand
The purpose of this study was to assess the efficacy of a single dose of the drug nevirapine (NVP) given to pregnant women at onset of labor and to their infant 48-72 hours after birth in addition to standard oral zidovudine (ZDV…
- Trial name
- NCT00398684
- Testing
- Single dose nevirapine to the mother and to the child
- Where
- Thailand
- Volunteers
- 1,792 people
- Sponsor
- Institut de Recherche pour le Developpement